General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018
E Grünig, N Benjamin, U Krüger, H Kaemmerer… - International journal of …, 2018 - Elsevier
In the summer of 2016, delegates from the German Respiratory Society, the German Society
of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to …
of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to …
Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018
MM Hoeper, C Apitz, E Grünig, M Halank… - International journal of …, 2018 - Elsevier
In the summer of 2016, delegates from the German Respiratory Society, the German Society
of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to …
of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to …
Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010
HA Ghofrani, O Distler, F Gerhardt… - Deutsche …, 2010 - europepmc.org
The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension
have been adopted for Germany. The guidelines contain detailed recommendations for the …
have been adopted for Germany. The guidelines contain detailed recommendations for the …
[HTML][HTML] Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011
HA Ghofrani, O Distler, F Gerhardt, M Gorenflo… - International journal of …, 2011 - Elsevier
The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension
have been adopted for Germany. The guidelines contain detailed recommendations on the …
have been adopted for Germany. The guidelines contain detailed recommendations on the …
Challenges in the diagnosis and treatment of pulmonary arterial hypertension
JL Vachiéry, S Gaine - European respiratory review, 2012 - Eur Respiratory Soc
Advances in the diagnosis and management of pulmonary arterial hypertension (PAH) have
resulted in significant improvements in outcomes for patients with this devastating and …
resulted in significant improvements in outcomes for patients with this devastating and …
Physicians' and patients' expectations of therapies for pulmonary arterial hypertension: where do they meet?
LS Howard, P Ferrari, S Mehta - European Respiratory Review, 2014 - Eur Respiratory Soc
In recent years, many new, effective therapies for pulmonary arterial hypertension (PAH)
have become available and are widely used, yet the long-term prognosis for patients with …
have become available and are widely used, yet the long-term prognosis for patients with …
Pulmonary arterial hypertension: tailoring treatment to risk in the current era
S Gaine, V McLaughlin - European Respiratory Review, 2017 - Eur Respiratory Soc
Recent advances in the treatment of pulmonary arterial hypertension (PAH) have led to
improved patient outcomes. Multiple PAH therapies are now available and optimising the …
improved patient outcomes. Multiple PAH therapies are now available and optimising the …
New therapeutic paradigms and guidelines in the management of pulmonary arterial hypertension
NS Hill, MJ Cawley, CL Heggen-Peay - Journal of managed care & …, 2016 - jmcp.org
BACKGROUND: Recent and ongoing developments in the diagnosis, treatment, and
management of pulmonary arterial hypertension (PAH) provide deeper insights into …
management of pulmonary arterial hypertension (PAH) provide deeper insights into …
[HTML][HTML] Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era
JGE Zelt, J Sugarman, J Weatherald… - European …, 2022 - Eur Respiratory Soc
Background The evolution in pulmonary arterial hypertension (PAH) management has been
summarised in three iterations of the European Society of Cardiology/European Respiratory …
summarised in three iterations of the European Society of Cardiology/European Respiratory …
Assessment of clinical worsening end points as a surrogate for mortality in pulmonary arterial hypertension: a systematic review and meta-analysis of randomized …
Background: Clinical worsening (CW) is a composite end point commonly used in
pulmonary arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of …
pulmonary arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of …